Yuri Martina has joined Destiny Pharma Plc as chief medical officer to help it advance its Phase 3 development plans for medicines to prevent infectious diseases. Dr Martina is a medical doctor who holds a PhD in genetics and molecular biology. Most recently he was deputy CMO at Grünenthal Group. Throughout his career he has contributed to multiple regulatory submissions to the European Medicines Agency and the US Food and Drug Administration.
Destiny Pharma announced the appointment on 3 May 2022.
Copyright 2022 Evernow Publishing Ltd